VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (6)
ELAV-Like Protein 1
Forkhead Box Protein L2
Fractionation, Field Flow
PEREIRA, FARIA
Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes.
Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes. Obesity (Silver Spring). 2011 Dec; 19(12):2310-5.
View in:
PubMed
subject areas
Adiponectin
Adipose Tissue
Alanine Transaminase
Aspartate Aminotransferases
Biomarkers
Blood Glucose
Body Mass Index
Body Weight
Diabetes Mellitus, Type 2
Drug Therapy, Combination
Fasting
Fatty Acids, Nonesterified
Glucagon-Like Peptide-1 Receptor
Humans
Hypoglycemic Agents
Liver
Magnetic Resonance Spectroscopy
Metformin
Middle Aged
Obesity
Peptides
PPAR gamma
Receptors, Glucagon
Thiazolidinediones
Triglycerides
Venoms
authors with profiles
MANDEEP BAJAJ